XBiotech starts phase II trial of vilamakitug for axial spondyloarthritis
Go back to XBiotech starts phase II trial of vilamakitug for axial spondyloarthritis| (NASDAQ: XBIT) | Delayed: 2.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.31 | 52 Week High | $25.00 | |||
| Open | $2.34 | 52 Week Low | $6.36 | |||
| Day High | $2.35 | P/E | N/A | |||
| Day Low | $2.30 | EPS | $0.00 | |||
| Volume | 43,575 | |||||
